Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 5, 2010, Pages 519-525

  Compañy, Luis ^a   Zapater, Pedro ^a   Pérez Mateo, Miguel ^a   Jover, Rodrigo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Extrapyramidal signs; Hepatic encephalopathy; Liver cirrhosis

Indexed keywords

ADULT; ARTICLE; BODY POSTURE; BRADYKINESIA; CHRONIC LIVER DISEASE; CHRONIC LIVER DISEASE QUESTIONNAIRE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFIDENCE INTERVAL; DISEASE COURSE; EXTRAPYRAMIDAL SYMPTOM; FACIAL EXPRESSION; FEMALE; FINGER; FOLLOW UP; GAIT; HAND GRIP; HAND MOVEMENT; HAZARD RATIO; HEPATIC ENCEPHALOPATHY; HUMAN; LEG MOVEMENT; LIVER CIRRHOSIS; MALE; MENTAL HEALTH; NUMBER CONNECTION TEST; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC TEST; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RIGIDITY; SHORT FORM 36; SPEECH ANALYSIS; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; COGNITION DISORDERS; DISEASE PROGRESSION; EXTRAPYRAMIDAL TRACTS; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77951268969     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328333df0f     Document Type: Article

References (30)

1. Ferenci P, Lockwood A, Mullen K, Tarter R,Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35:716-721.
2. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30:890-895.
3. Hui AY, Chan HL, Leung NW, Hung LC, Chan FK, Sung JJ. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol 2002; 34:569-572.
4. Jover R, Company L, Gutierrez A, Lorente M, Zapater P, Poveda MJ, et al. Clinical significance of extrapyramidal signs in patients with cirrhosis. J Hepatol 2005; 42:659-665.
5. Groeneweg M, Quero JC, De Bruijin I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28:45-49.
6. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39:739-745. (Pubitemid 38337653)
7. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96:2718-2723.
8. Spahr L, Butterworth RF, Fontaine S, Bui L, Therrien G, Milette PC, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996; 24:1116-1120.
9. Spahr L, Vingerhoets F, Lazeyras F, Delavelle J, DuPasquier R, Giostra E, et al. Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology 2000; 119:774-781.
10. Burkhard PR, Delavelle J, Du PR, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 2003; 60:521-528.
11. Jover R, Company L, Gutierrez A, Zapater P, Perez-Serra J, Girona E, et al. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Am J Gastroenterol 2003; 98:1599-1604.
12. Victor M, Adams RD, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 1965; 44:345-396.
13. Krieger S, Jauss M, Jansen O, Stiehl A, Sauer P, Geissler M, et al. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation. J Hepatol 1997; 27:121-126.
14. Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977; 22:541-550.
15. Lezak MD. A compendium of tests and assessment techniques. In: Lezak MD, editor. Neuropsychological assessment. New York: Oxford University Press; 1993. pp. 311-328.
16. Ruff RM, Parker SB. Gender- and age-specific changes in motor speed and eye-hand coordination in adults: normative values for the finger tapping and grooved pegboard tests. Percept Mot Skills 1993; 76 (3 Pt 2):1219-1230.
17. Treisman A, Fearnley S. The Stroop Test: selective attention to colours and words. Nature 1969; 222:437-439.
18. Hely MA, Chey T, Wilson A, Williamson PM, O'Sullivan DJ, Rail D, et al. Reliability of the Columbia scale for assessing signs of Parkinson's disease. Mov Disord 1993; 8:466-472.
19. Alonso J, Prieto L, Anto JM. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin (Barc) 1995; 104:771-776.
20. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999; 45:295-300.
21. Ferrer M, Cordoba J, Garin O, Olive G, Flavia M, Vargas V, et al. Validity of the Spanish version of the chronic liver disease questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl 2006; 12:95-104.
22. Hauser RA, Zesiewicz TA, Martinez C, Rosemurgy AS, Olanow CW. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci 1996; 23:95-98.
23. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346:270-274.
24. Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A, et al. Manganese deposition in basal ganglia structures results from both portalsystemic shunting and liver dysfunction. Gastroenterology 1999; 117:640-644.
25. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95:2029-2034.
26. Romero-Gomez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002; 37:781-787.
27. Timmermann L, Gross J, Kircheis G, Haussinger D, Schnitzler A. Cortical origin of mini-asterixis in hepatic encephalopathy. Neurology 2002; 58:295-298.
28. Cauli O, Llansola M, Erceg S, Felipo V. Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. J Hepatol 2006; 45:654-661.
29. Cauli O, Mlili N, Rodrigo R, Felipo V. Hyperammonaemia alters the mechanisms by which metabotropic glutamate receptors in nucleus accumbens modulate motor function. J Neurochem 2007; 103:38-46.
30. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 2007; 46:514-519.